Eighth EMA-Medicines for Europe bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 9 September 2025, 15:00 (CEST) to 9 September 2025, 17:00 (CEST)

Submitted by Anonymous (not verified) on 14 August 2025 - 9:25

Eighth EMA-Medicines for Europe bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 9 September 2025, 15:00 (CEST) to 9 September 2025, 17:00 (CEST)

Human medicines European public assessment report (EPAR): Exparel liposomal, bupivacaine, Date of authorisation: 16/11/2020, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 13 August 2025 - 14:41

Human medicines European public assessment report (EPAR): Exparel liposomal, bupivacaine, Date of authorisation: 16/11/2020, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Stribild, elvitegravir,cobicistat,emtricitabine,tenofovir disoproxil, Date of authorisation: 24/05/2013, Revision: 27, Status: Authorised

Submitted by Anonymous (not verified) on 13 August 2025 - 14:33

Human medicines European public assessment report (EPAR): Stribild, elvitegravir,cobicistat,emtricitabine,tenofovir disoproxil, Date of authorisation: 24/05/2013, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Enbrel, etanercept, Date of authorisation: 02/02/2000, Revision: 76, Status: Authorised

Submitted by Anonymous (not verified) on 13 August 2025 - 8:19

Human medicines European public assessment report (EPAR): Enbrel, etanercept, Date of authorisation: 02/02/2000, Revision: 76, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness